Macroprolactinemia in a Patient with Invasive Macroprolactinoma: A Case Report and Minireview

Table 1

Main clinical, laboratory, and instrumental findings.

Parameters	35-year-old female patient
	Baseline	1-Year Follow-up^1
Prolactin, PRL (mIU/mL)	10 610	295
Macroprolactin, MPRL (mIU/mL)	10 107	106
Recovery, %	4.7%	36%
Tumor size (mm) (on MRI)	21 × 13 mm	9 × 8 mm
Body mass index, BMI (kg/m^2)	31.2%	28.6%
Main patient’s complaints	Severe headache; blurred vision	No headache; normal vision
Hirsutism, Ferriman-Gallwey score	13	13
Menstrual cycle	Secondary amenorrhea	Regular
Pelvic ultrasound	Anovulation	Normal

¹Treatment with Cabergoline 2.0 mg/week; cumulative dose = 96 mg.